These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of diabetes on methamphetamine-induced place preference in mice.
    Author: Kamei J, Ohsawa M.
    Journal: Eur J Pharmacol; 1996 Dec 30; 318(2-3):251-6. PubMed ID: 9016912.
    Abstract:
    The effects of diabetes on methamphetamine-induced place preference in mice were examined. Methamphetamine caused a dose-dependent place preference in both diabetic and non-diabetic mice. Methamphetamine preferentially induced place preference in diabetic mice as compared to those in non-diabetic mice. Indeed, methamphetamine-induced place preference at a dose of 0.3 mg/kg in diabetic mice was similar to that at 3 mg/kg in non-diabetic mice. Furthermore, methamphetamine-induced place preference in both diabetic and non-diabetic mice was significantly antagonized by pretreatment with quinpirole, a dopamine D2/D3 receptor agonist. Methamphetamine-induced place preference was also antagonized by pretreatment with 7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT), a selective dopamine D3 receptor agonist. On the other hand, 7-OH-DPAT produced significant place aversion in non-diabetic mice. 7-OH-DPAT produced neither place preference nor place aversion in diabetic mice. These results suggest that methamphetamine-induced place preference may be modulated by dopamine D3 receptors. Furthermore, increased dopamine neurotransmission associated with the down-regulation of presynaptic dopamine D3 receptor-mediated functions may account for the enhancement of methamphetamine's reinforcing effect in diabetic mice.
    [Abstract] [Full Text] [Related] [New Search]